Page last updated: 2024-10-28

hexamethonium and Rheumatoid Arthritis

hexamethonium has been researched along with Rheumatoid Arthritis in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanashiro, A1
Talbot, J1
Peres, RS1
Pinto, LG1
Bassi, GS1
Cunha, TM1
Cunha, FQ1
PLATT, WD1
STEINBERG, IH1

Other Studies

2 other studies available for hexamethonium and Rheumatoid Arthritis

ArticleYear
Neutrophil Recruitment and Articular Hyperalgesia in Antigen-Induced Arthritis are Modulated by the Cholinergic Anti-Inflammatory Pathway.
    Basic & clinical pharmacology & toxicology, 2016, Volume: 119, Issue:5

    Topics: Animals; Antigens; Arthritis, Experimental; Arthritis, Rheumatoid; Atropine Derivatives; Cholinergic

2016
The treatment of rheumatoid arthritis with hexamethonium chloride: a preliminary report.
    Annals of internal medicine, 1955, Volume: 42, Issue:4

    Topics: Arthritis; Arthritis, Rheumatoid; Cardiovascular Agents; Hexamethonium; Muscle Relaxants, Central

1955